• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Gsk Plc ADR (NY: GSK )

    39.84 +0.94 (+2.42%)
    Official Closing Price Updated: 4:10 PM EDT, Jul 17, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,754,211
    Open 39.20
    Bid (Size) 39.85 (2)
    Ask (Size) 39.94 (1)
    Prev. Close 38.90
    Today's Range 39.14 - 39.94
    52wk Range 33.67 - 45.92
    Shares Outstanding 5,385,189,617
    Dividend Yield 3.62%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    European Commission Faces Court Criticism Over COVID Vaccine Contract Transparency Ahead Of Vote on Ursula Von Der Leyen's Reappointment
    European Commission faces scrutiny over COVID vaccine contract transparency ahead of key vote. Legal challenges and implications discussed. 
    Via Benzinga
    Exposures COVID-19
    Is GSK a Top-Value Stock Right Now?
    GSK, a multinational pharma company, scans as a bargain. 
    Via The Motley Fool

    Performance

    YTD
    +6.21%
    +6.21%
    1 Month
    -2.02%
    -2.02%
    3 Month
    -0.28%
    -0.28%
    6 Month
    -0.10%
    -0.10%
    1 Year
    +15.44%
    +15.44%

    More News

    Read More
    3 Top Cancer Treatment Stocks to Buy Now
    Via InvestorPlace
    Positive News is Driving This Cancer Drug Maker’s Stock Higher
    Via MarketBeat
    The 3 Most Undervalued Pharma Stocks to Buy in July 2024
    Via InvestorPlace
    Topics Economy
    Exposures Economy
    GSK Begins Shipping Influenza Vaccine Doses for 2024-25 Season
    From GSK plc
    Via Business Wire
    3 Dirt-Cheap Drug Developers With Blockbuster Potential
    Via InvestorPlace
    Health Officials Keep Close Eye On Bird Flu As It Infects Cows For The First Time
    Via Benzinga
    The 3 Most Undervalued Under-$50 Stocks to Buy in July 2024
    Via InvestorPlace
    Pfizer's RSV Vaccine Abrysvo Clears Concerns Over Preterm Birth Risk, Safety For Pregnant Women, New Study Shows
    Via Benzinga
    United Kingdom Stocks, ETFs To Watch After Keir Starmer, Labour Party Win
    Via Benzinga
    Topics ETFs
    Upcoming Stock Spinoffs: Should You Pounce or Pass?
    Via InvestorPlace
    CureVac Layoffs 2024: What to Know About the Latest CVAC Job Cuts
    Via InvestorPlace
    Topics Workforce
    Exposures Layoff
    CVAC Stock Alert: CureVac Pops on Licensing Deal With GSK
    Via InvestorPlace
    GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
    Via Benzinga
    Exposures COVID-19
    3 No-Brainer Stocks to Buy With $300 Right Now for the Second Half of 2024
    Via The Motley Fool
    Heartburn Drug Zantac Litigation: GSK And Other Pharma Giants Face Trial Over Cancer Claims
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Legal
    CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK
    Via Benzinga
    Why Is Moderna Stock Trading Lower On Wednesday?
    Via Benzinga
    Exposures COVID-19
    Moderna Crumbles After RSV Vaccine Effectiveness Pales Vs. Pfizer, GSK Shots
    Via Investor's Business Daily
    Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC
    Via Benzinga
    UK Chooses Pfizer Over GSK for Multi-Million Dose RSV Vaccine Contract
    Via Benzinga
    Industry Groups Back GSK's Effort To Halt 70,000 Lawsuits Associated With Heartburn Drug Zantac Caused Cancer
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Legal
    Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
    Via FinancialNewsMedia
    Topics Death
    Exposures Death
    Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
    From FN Media Group LLC
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.